 TCTMD | DES Noninferior for Survival Compared with BMS in STEMI TCTMD EXAMINATION, conducted at 12 centers in Italy, Spain and the Netherlands, was a randomized, controlled trial comparing outcomes for 751 patients assigned to an everolimus-eluting stent (Xience V, Abbott Vascular) with those of 747 patients assigned to ... |
